Cell Therapies Pty Ltd. is excited to announce the opening of new cell and gene therapy GMP manufacturing facilities to meet future patient demand at the Peter MacCallum Cancer Centre. As Australia’s only biomedical manufacturing facility where CAR T-cells and other “living” cancer therapies can be made at a commercial scale, this expansion increases capacity to support high throughput manufacture of commercial cell and gene therapy products for Australian patients and the Asia Pacific market. “The facilities in Melbourne, Australia, are now on par with only a handful of sites globally and combined with a highly specialised workforce, mean we have the ability to make more of these innovative treatments to support the growing demand in APAC,” said Acting Chief Executive of Cell Therapies Pty Ltd, Associate Professor Dominic Wall. Learn more via our media release: https://lnkd.in/gD278WmS
Cell Therapies Pty Ltd
Biotechnology Research
Melbourne, VIC 9,102 followers
GMP contract manufacturer of cell-based therapies serving the global market
About us
Cell Therapies Pty Ltd is a contract development and manufacturing organization (CDMO) that manufactures and deploys advanced cell-based therapies to the global market. Established in 2003, Cell Therapies is one of the most experienced GMP compliant manufacturers of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products globally. We have a 13-cleanroom GMP facility that meets global regulatory and international organisation for standardisation (ISO) standards benchmarked by the Pharmaceutical Inspection Convention/Cooperation Scheme (PIC/S). Our services cover the complete manufacturing process from development to deployment, providing needle-to-needle control with clinical integration. Our facility is co-located with the Peter MacCallum Cancer Centre in Melbourne, Australia, providing access to hospitals, research institutes, and universities to support product development, translation to the clinic, and patient access. Please contact us through our website to discuss potential collaborations.
- Website
-
http://www.celltherapies.com.au
External link for Cell Therapies Pty Ltd
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Melbourne, VIC
- Type
- Privately Held
- Founded
- 2003
- Specialties
- cell therapy manufacturing, GMP manufacturing, gene therapy manufacturing, apheresis management, GMP consulting, cellular immunotherapies, clinical trial support, CAR-T cell manufacturing, and CAR-T therapy
Locations
-
Primary
Get directions
Level 9, VCCC Building
305 Grattan Street
Melbourne, VIC 3000, AU
Employees at Cell Therapies Pty Ltd
-
Dominic Wall
Executive responsible for specialised healthcare business ventures/ Expert in cell therapy & cancer diagnostics
-
Nathan Smith
Director of Business Development at Cell Therapies Pty Ltd
-
Michelle Burke
Non-executive director I PBAC member I Health, Pharmaceuticals and Biotechnology
-
Jennifer Hollands
Cell & Gene Therapies | Stakeholder Engagement
Updates
-
Cell Therapies Pty Ltd reposted this
Great insights from our very own CEO Bev Menner, who recently featured on Aleda's 'Empowering Leaders' podcast to share her experiences in the biotech industry and the unique challenges and opportunities faced. Watch the full episode to hear her thoughts on leadership in biotech and the drive to make a meaningful impact on patients' lives. 👇
Today’s guest on the Empowering Leaders podcast is Bev Menner, CEO of Cell Therapies Pty Ltd, a biotech company leading the way in next generation cancer and immune disease therapies. With an affinity for science and a genuine love of people and connection, Bev has had an extraordinarily successful and varied career in the field of medical science. Here, she tells Luke Darcy how all her former roles have prepared her in some way for her current position; leading a team of cell and gene therapy experts who are saving the lives of those affected by cancer. In this episode, Bev talks about being at the coalface of the hugely collaborative development of the Covid vaccine, and what she hopes we can learn from that period to better prepare society on a more holistic level in the future. She also discusses her positive experience being raised in an adoptive family, her love of the Aleda Connect program, the fascinating world of wallaby lactation and much more. You can listen to the full episode here 👉 https://bit.ly/46QXhP3
-
Great insights from our very own CEO Bev Menner, who recently featured on Aleda's 'Empowering Leaders' podcast to share her experiences in the biotech industry and the unique challenges and opportunities faced. Watch the full episode to hear her thoughts on leadership in biotech and the drive to make a meaningful impact on patients' lives. 👇
Today’s guest on the Empowering Leaders podcast is Bev Menner, CEO of Cell Therapies Pty Ltd, a biotech company leading the way in next generation cancer and immune disease therapies. With an affinity for science and a genuine love of people and connection, Bev has had an extraordinarily successful and varied career in the field of medical science. Here, she tells Luke Darcy how all her former roles have prepared her in some way for her current position; leading a team of cell and gene therapy experts who are saving the lives of those affected by cancer. In this episode, Bev talks about being at the coalface of the hugely collaborative development of the Covid vaccine, and what she hopes we can learn from that period to better prepare society on a more holistic level in the future. She also discusses her positive experience being raised in an adoptive family, her love of the Aleda Connect program, the fascinating world of wallaby lactation and much more. You can listen to the full episode here 👉 https://bit.ly/46QXhP3
-
The cell and gene therapy landscape in Australia and the broader APAC region is evolving rapidly, offering unique opportunities for innovation and collaboration. This insightful article from Avance Clinical and our own Jennifer Hollands at Cell Therapies explores the nuances of conducting clinical studies in this dynamic space. Whether you’re a researcher, biotech start-up, or established player in the industry, these insights can help navigate the complexities and seize emerging opportunities. See the full article at: https://lnkd.in/e9Fd6dRe
Demystifying Cell and Gene Therapy Studies in Australia and the Broader APAC Region - Avance Clinical
avancecro.com
-
📢 We’re Hiring! 📢 - MANUFACTURING SCIENTIST Cell Therapies are seeking a motivated individual for an exciting role. As a Manufacturing Scientist, you will be tasked to perform critical aseptic manufacturing processes involving cell culture of CAR-T Cells and others for clinical and commercial cellular therapy products. Sound interesting? Apply at: https://lnkd.in/eFvUPFz8
-
-
📢 We’re Hiring! 📢 - DOCUMENT ADMINISTRATOR Cell Therapies are seeking a motivated Document Administrator to ensure documents are managed as per the Quality Management System and ensure QMS, GMP compliance for the clinical and commercial manufacturing and distribution of cellular and tissue therapy products. All applicants to apply via the following link: https://lnkd.in/eDYp2Nmr
-
-
We're so excited to be part of the inaugural Cell and Gene Summit at #AusBiotech2024!
Executive leader | Non-Executive Director | Ecosystem builder collaborating for impact | Science | Strategy | Advocacy | Career coaching | Inclusion and allyship | Changemaker | Keynote and MC
Australia’s first industry-led Cell and Gene Summit has kicked off with a full house at #AusBiotech2024 today! The energy in the room has been palpable to say the least. Thanks to AusBiotech CEO, Rebekah Cassidy, for officially opening the Cell and Gene Summit. Today’s Cell and Gene Summit brings together Australia’s vibrant cell and gene ecosystem and marks the beginning of a national conversation to accelerate this rapidly growing sector to get these advanced therapies to patients faster. Our comprehensive Opening Keynote by Abhishek Gupta emphasised the need for such a holistic approach to ensure successful translation of these innovative therapeutics. Thanks to Elizabeth de Somer for chairing this session and to Syneos Health for sponsoring. An exciting program ahead which explores key priority areas for the sector - streamlined market access and sustainable funding pathways, national manufacturing needs, challenges and opportunities in commercialisation and progressing and attracting clinical trials in Australia. #AusCatalyst #CGSummit24
-
-
-
-
-
+1
-
-
Cell Therapies Pty Ltd reposted this
Thanks University of Melbourne Biotechnology Club for a great networking event. Always enjoy the conversations I get to have about the cell and gene therapy sector with highly engaged and passionate students. Best of luck with your biotech careers! #cellandgenemanufacturing #cellandgenetherapies
On the 10th of October, we hosted an incredible Speed Networking Night, bringing together University of Melbourne students and 14 industry professionals from diverse fields within biotechnology. It was a fantastic opportunity for students to connect with experienced professionals in a casual, dynamic setting! Check out some highlights from the event below! Throughout the evening, participants had insightful conversations about career paths, industry trends, and biotech innovations. The energy in the room was unmatched and it was amazing to witness meaningful connections being made with mentors and future colleagues. A huge thank you to our guest industry professionals; Pauline (Quy Binh) Deng, Katherine Jackman, Christopher Wraight, Gowtam Chowdary Chalasani, Naveen Vankadari, PhD, Esther L., Jennifer Hollands, Yi-Kai Chen, PhD, Ting Ting L., Wendy J Musgrove, Chris Ozga, Sant-Rayn Pasricha, Ashley G. and Dr Christina Chang for taking the time to share their knowledge and advice. Your generosity in supporting the next generation of biotech professionals does not go unnoticed! A big thank you to the organising team; Jessica Zhang, Alarmel mangai Sathappan, Celine Fang, Hsiang-Er Michelle Lee, Lady Feren Pangjaya, Kylie Liang, Ayush Namboothiri, Josiah Tong, Yash Patel, Deeptha Madhavan, Liam Wesp, cheryl wong, Shih Yuan (Linda) Lu, Rimjhim Mehan and Shannon Wang for your hard work behind the scenes – you made it all possible! We look forward to bringing you more events in 2025! Until then, stay curious and keep building those connections! Good luck with exams, happy holidays and see you next year!
-
-
-
-
-
+15
-
-
Job Opportunity Alert !! - Manufacturing Scientist We are seeking a motivated cleanroom Manufacturing Scientist to join our growing team. As a Manufacturing Scientist, you will be tasked to perform critical aseptic manufacturing processes for clinical and commercial cellular therapy products. Applications through SEEK only - https://lnkd.in/ehi-rdXR Application date closes 31st of October.
-
-
We are excited to be part of the Study Melbourne International Student Careers Fair! Visit us at our booth on 25 September between 10am – 2pm to learn about careers in the Cell and Gene Therapy Advanced Manufacturing industry. Speak to our team about how their studies set them up for successful careers and what it’s like to work at Cell Therapies. Ready to take the next step? Learn more and secure your spot by registering here: https://lnkd.in/dGbG-3u8 Amelia Jalanski Josh Downing Yiqin Zhu Jennifer Hollands Nikolce Kocovski Hazem Alkazemi Kate MacCormack Dominic Wall Bev Menner #Cellandgene, #cellmanufacturing, #CART. #CDMO, #cellulartherapies
-